Lack Of Diversity in Clinical Trials: A Conversation

During the 2022 C3 Summits held in Princeton, NJ; Raleigh, NC; and London, England; TransPerfect Life Sciences was delighted to welcome a host of subject matter experts to deliver their insights on a series of conversations on clinical content. Throughout these events, we focused on two key topics pertinent to the greater life sciences industry: diversity in clinical research and decentralized trials.

Our London session invited experts in the clinical space to share their perspectives on the existing landscape of clinical trials and how pharmaceutical organizations can adapt their processes to drive patient diversity in their research. Check out our key takeaways from this session that include delving into the existing clinical landscape and what actions to take moving forward. Also, look for our second blog in this series, which will focus on decentralized trials.